<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04319913</url>
  </required_header>
  <id_info>
    <org_study_id>20MMHIS069e</org_study_id>
    <nct_id>NCT04319913</nct_id>
  </id_info>
  <brief_title>ANI-guided Intraoperative Analgesia in Low-pressure Anesthesia</brief_title>
  <official_title>Whether Intraoperative Analgesia Guided by the Analgesia Nociception Index (ANI) Can Decrease the Amount of Narcotics, Other Anesthetic Drugs, and Blood Loss in Patients Undergoing Low-pressure Anesthesia: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mackay Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During functional endoscopic sinus surgery(FESS), low-pressure anesthesia is often applied,
      aiming to decreased operative blood loss, and anesthetics, narcotics and antihypertensive
      agents are given to achieve desirable low blood pressure. However, the dose of these
      medications given is usually decided subjectively based on the clinical experience of the
      care provider, placing the patient in a risky situation of narcotics overdosing or
      underdosing. Therefore, here is the question: Whether intraoperative analgesia guided by an
      objective pain monitoring device, such as the Analgesia Nociception Index (ANI), could
      decrease the amount of narcotics, other anesthetic agents, and blood loss in patients
      undergoing low-pressure anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Analgesia nociception index (ANI) is an objective pain monitoring device, it could measure
      parasympathetic tone base on heart rate variability analysis, which is a way to measure the
      effect of respiratory sinus arrhythmia on heart rate. In the previous studies, ANI had been
      used to predict immediate postoperative pain, intraoperative analgesia in children, and
      intraoperative analgesia in bariatric surgery, which showed ANI can be used to detect
      surgical stimuli, reduce intraoperative consumption of narcotics, and assess immediate
      postoperative pain intensity. However, no publication has mentioned ANI been used in
      low-pressure anesthesia.

      Participants with ASA physical status class I or II, age between 20-65, and body mass index
      less than 35 who would undergo FESS are enrolled and randomly allocated by using
      computer-generated random number table into two groups with equal probability: ANI-guided
      remifentanil titration or remifentanil titration by standard care. Total intravenous
      anesthesia with propofol TCI(target controlled infusion) and remifentanil TCI are used for
      anesthesia maintenance, targeting bispectral index between 40 and 60. The ANI value in
      experimental group would be maintained between 50 and 70. Intraoperative mean arterial
      pressure (MAP) would be targeted at 55-65 mmHg, and calcium channel blocker would be
      administered if MAP could not achieve target despite of propofol and remifentanil titration.

      Participant's demographics, baseline information, type and duration of the operation,
      duration from end of the surgery till participant awaken, ANI value, vital signs, the amount
      of narcotics, anesthetics and antihypertensive medications used, intraoperative blood loss,
      surgeon's satisfaction to the operation field, participant first recorded pain score in
      postoperative recovery room using visual analogue scale, and opioid-associated side effects
      such as nausea, vomiting, pruritis, dizziness in postoperative recovery room, will be
      recorded and analyzed. The statisticians will apply Chi-square for categorical data, T-test
      for continuous data, and multiple regressions analysis. P value less than 0.05 was considered
      statistically significant. Using G-power software to estimate, predicted sample size is 120
      presuming type I error 0.05, power 0.95, and medium effect size.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The analgesia nociception index sensors are a pair of patches. They would be placed on the participant's right shoulder and the left side of the chest before the induction of general anesthesia, recording the ANI value throughout the operation. In the control group, the ANI monitor would be covered up, so that the care provider could only titrate remifentanil based on clinical experience. The participants would be masked from which group they were allocated into. The surgeon would be masked from the participant's allocation, and surgeon's satisfaction to the operation field would be surveyed by a questionnaire right after the operation, also the estimated blood loss amount would be recorded by the same surgeon.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Narcotics consumption</measure>
    <time_frame>From the first given dose of remifentanil until the last given given dose of remifentanil during anesthesia, assessed up to 8 hours.</time_frame>
    <description>Remifentanil would be used as narcotics, the total amount used intraoperatively would be recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anesthetics consumption</measure>
    <time_frame>From the first given dose of anesthetics (propofol or midazolam, whichever comes first) until the last given given dose of anesthetics (propofol or midazolam, whichever comes last), assessed up to 8 hours.</time_frame>
    <description>The amount of anesthetics (mainly propofol) used intraoperatively would be recorded</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Blood loss</measure>
    <time_frame>the estimated blood loss would be recorded immediately after the operation</time_frame>
    <description>Blood loss would be estimated by surgeon</description>
  </other_outcome>
  <other_outcome>
    <measure>Bleeding of the operation field</measure>
    <time_frame>The questionnaire would be provided to the surgeon immediately after the operation</time_frame>
    <description>Bleeding of the operation field would be surveyed to surgeons by a questionnaire.
The clarity of operation field:
Minimal bleeding: no need of suction.
Slightly bleeding: suction sometimes.
Moderate bleeding: Suction frequently
Severe bleeding: surgical field compromised even right after suction
Continuous bleeding.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Analgesia</condition>
  <condition>Functional Endoscopic Sinus Surgery</condition>
  <condition>Heart Rate Variability</condition>
  <condition>Opioid Consumption</condition>
  <arm_group>
    <arm_group_label>ANI-guided</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ANI-guided narcotics use to maintain ANI value between 50 to 70</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>narcotics use guided by clinical experience, ANI is still recorded but would be covered up intraoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>analgesia nociception index</intervention_name>
    <description>Analgesia nociception index (ANI) could objectively monitor how pain the participant is. In the experimental group, the care provider would decrease the dose of narcotics (remifentanil) if the ANI value is above 70, and increase the dose if the ANI value is under 50.</description>
    <arm_group_label>ANI-guided</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status class I or II

          -  age between 20-65

          -  body mass index less than 35

          -  scheduled for functional endoscopic sinus surgery

        Exclusion Criteria:

          -  major cardiovascular disease, arrhythmia, respiratory disease, cerebral vascular
             disease, or ASA physical status classification III or greater

          -  documented or self-reported history of chronic pain

          -  acute or chronic opioid analgesic use

          -  dysautonomia

          -  diabetes mellitus with evidence of neuropathy

          -  emergency cases

          -  allergy to medications in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chien-Chung Huang, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mackay Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chien-Chung Huang, MD</last_name>
    <phone>+886225433535</phone>
    <phone_ext>3009</phone_ext>
    <email>cchuang@dr.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>MacKay Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>104</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Boselli E, Bouvet L, BÃ©gou G, Dabouz R, Davidson J, Deloste JY, Rahali N, Zadam A, Allaouchiche B. Prediction of immediate postoperative pain using the analgesia/nociception index: a prospective observational study. Br J Anaesth. 2014 Apr;112(4):715-21. doi: 10.1093/bja/aet407. Epub 2013 Dec 8.</citation>
    <PMID>24322571</PMID>
  </reference>
  <reference>
    <citation>Julien-Marsollier F, Rachdi K, Caballero MJ, Ayanmanesh F, Vacher T, Horlin AL, Skhiri A, Brasher C, Michelet D, Dahmani S. Evaluation of the analgesia nociception index for monitoring intraoperative analgesia in children. Br J Anaesth. 2018 Aug;121(2):462-468. doi: 10.1016/j.bja.2018.03.034. Epub 2018 Jun 5.</citation>
    <PMID>30032886</PMID>
  </reference>
  <reference>
    <citation>Le Gall L, David A, Carles P, Leuillet S, Chastel B, Fleureau C, Dewitte A, Ouattara A. Benefits of intraoperative analgesia guided by the Analgesia Nociception Index (ANI) in bariatric surgery: An unmatched case-control study. Anaesth Crit Care Pain Med. 2019 Feb;38(1):35-39. doi: 10.1016/j.accpm.2017.09.004. Epub 2017 Oct 12.</citation>
    <PMID>29033356</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2020</study_first_posted>
  <last_update_submitted>March 22, 2020</last_update_submitted>
  <last_update_submitted_qc>March 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mackay Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Chien-Chung,Huang</investigator_full_name>
    <investigator_title>Attending physician of anesthesiology , Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>analgesia nociception index</keyword>
  <keyword>functional endoscopic sinus surgery</keyword>
  <keyword>analgesia</keyword>
  <keyword>opioid consumption</keyword>
  <keyword>heart rate variability</keyword>
  <keyword>low pressure anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

